businesspress24.com - Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integ
 

Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration

ID: 1266917

Enhanced Communication Between Dermatologists and Pathologists

(firmenpresse) - BOCA RATON, FL -- (Marketwired) -- 09/25/13 -- , the creator of the Electronic Medical Assistant (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, and Miraca Life Sciences (MLS), a specialist in the development and commercialization of subspecialty expert anatomic pathology services, announced today that they are partnering to develop an enhanced diagnostic data bridge.

Pathologists normally analyze tissue samples with limited clinical background on patients, which can delay accurate diagnoses. EMA dermatologists and MLS pathologists will be able to share additional diagnostic information, which can help the pathologist create a more timely, informed and accurate analysis.

"This is truly the future of healthcare technology," said Dr. Michael Sherling, Chief Medical Officer and co-founder of Modernizing Medicine. "Structured data stored in the cloud with Modernizing Medicine's EMA EMR is the key to letting us share information with MLS. Working together, we intend to build an enhanced system to improve communications between dermatologists and pathologists which should ultimately help patients -- improved patient care through technology is what we're all about."

Modernizing Medicine's user-friendly EMA adapts to each healthcare provider's unique style of practice and integrates seamlessly into the practice's workflow, saving physicians and their staff time and increasing efficiencies. EMA's cloud-based approach to collecting and storing patient information enables physicians to utilize the EMA Network™ to create, visualize and consume treatment data to better care for their patients.

"Partnering with Modernizing Medicine is a natural fit, since we share the same goals of using technology to accelerate positive change in healthcare," said Richard Lash, MD, Chief Medical Officer of Miraca Life Sciences. "Miraca's existing structured data based on our consensus approach to diagnostic terminology and criteria will complement the rich clinical information provided by Modernizing Medicine, helping ensure the most definitive diagnoses for individual patients while creating a powerful database to help clinicians and pathologists improve patient outcomes."





Available as a native iPad application or from any web-enabled Mac or PC, Modernizing Medicine's EMA is developed by physicians for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets. This year, Software Advice named EMA the #1 tablet EHR and the company was listed on Forbes' annual ranking of America's Most Promising Companies.



is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Its product, , is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets, and to more than 1,000 physician practices across the country. In 2013 Modernizing Medicine was listed at No. 47 on Forbes' annual ranking of America's Most Promising Companies.



Serving more than 3,500 patients each day, is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.

Miraca Life Sciences, a wholly owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals -- all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It's part of our commitment: not only to scientific excellence, but to patients and practices.



For more information, contact:

Tara Auclair Ryan
561-880-2998 x321


Lauren Moreno
415-593-1400


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  BCMA: BC Doctors Champion Professionalism, Strong Relationships
UltraSPECT Software Proves to Be Viable Solution for Meeting ASNC Low Dose Guidelines in Facility Comparison of Nuclear Medicine Exams
Bereitgestellt von Benutzer: Marketwired
Datum: 25.09.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1266917
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BOCA RATON, FL


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 133 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration
"
steht unter der journalistisch-redaktionellen Verantwortung von

Modernizing Medicine (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Modernizing Medicine



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 2
Members online: 1
Guests online: 69


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.